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Abstract: In hypertension, the blood pressure curve may be divided into two sets of   components. 
The first set is mean arterial pressure, steady flow, and vascular resistance, thus acting on small 
arteries; the second set refers to large arteries, hence to pulse pressure, arterial stiffness, and 
wave reflections. The angiotensin-converting enzyme (ACE) inhibitor perindopril not only 
reduces mean arterial pressure but also acts specifically on pulse pressure. The effect on pulse 
pressure predominates on central rather than peripheral (brachial) large arteries, reducing aortic 
stiffness and most wave reflections. Such hemodynamic changes are not observed with standard 
β-blockade, which reduces aortic stiffness and brachial systolic and pulse pressure but not 
central pulse pressure and wave reflections. In hypertensive subjects, perindopril and other ACE 
inhibitors seem to predict more consistently the reduction of cardiovascular events, mainly of 
cardiac origin, than standard β-blockers alone. This effect is associated with the important 
biochemical finding that mechanotransductions of angiotensin and β-blockade are markedly 
different, acting in the former specifically on the α5β1 integrin complex and on the fibronectin 
ligand of arterial vessels.
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Introduction
Because they are the simple consequence of the well established auscultatory method, 
blood pressure (BP) measurements are usually obtained from the definition of only 
two specific points of the BP curve, ie, peak systolic BP and end diastolic BP. After 
the advent of antihypertensive therapy and following the results of therapeutic trials 
in populations of subjects with hypertension, it was proposed that cardiovascular 
effectiveness could be better evaluated from systolic BP than from diastolic BP. 
However, these standard definitions are oversimplified and now require substantial 
revision.
Blood pressure is the force applied per unit area on a given vessel, which determines 
the flow of blood. Pressure and flow result from the properties of the heart as a pump 
and the characteristics of the arterial system. However, pressure and flow vary during 
the cardiac cycle and are therefore called pulsatile pressure and flow. When the BP 
curve is submitted to Fourier analysis and written as a series of sine waves, these 
waves are called oscillatory pressure and flow. The zero term equals the mean value 
(mean arterial pressure) of BP, and the harmonics are the oscillatory terms, summarized 
by pulse pressure (pulse pressure = systolic BP – diastolic BP, see Figure 1).
After World War II, a group of cardiovascular physiologists suggested that the pulsatile 
BP curve could be better described when divided into two components, ie, a steady International Journal of Nephrology and Renovascular Disease 2010:3 submit your manuscript | www.dovepress.com
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component (mean arterial pressure) and a pulsatile component 
(pulse pressure), as shown in Figure 1. This review focuses 
on, firstly, the description of the hemodynamics of untreated 
hypertension according to the basic principles defined from 
mean arterial pressure and pulse pressure, and, secondly, 
application of these principles to the study of angiotensin 
blockade. Perindopril was the first angiotensin-converting 
enzyme (ACE) inhibitor to be studied in subjects with hyper-
tension using mean arterial pressure and pulse pressure. The 
role of the other ACE inhibitors in the mechanisms of angio-
tensin blockade is indicated in the Appendix.
Systemic hemodynamics  
in untreated hypertension
Large arteries have two distinct functions.1–4 The first consists 
of transporting blood from the heart toward peripheral tissues 
in order to satisfy their metabolic needs. This function requires 
the presence of a steady pressure gradient, represented prin-
cipally by mean arterial pressure. In order to define this gradi-
ent, mean arterial pressure, calculated from the cross-sectional 
area under the BP curve divided by cardiac cycle time, is 
subtracted from central venous pressure, which is normally 
close to zero. The second function of large arteries consists of 
instantaneously accommodating the volume of blood ejected 
from the left ventricle of the heart, storing part of the stroke 
volume during systolic ejection, and carrying this volume 
during diastole, thereby ensuring continuous perfusion of 
organs and tissues at the peripheral level. This specific function 
of arteries is usually described in terms of elasticity or stiffness 
of the aorta or an individual artery and is usually associated 
with the generation of wave reflections.
Large artery elasticity or stiffness is usually determined from 
systolic and diastolic changes in artery diameter, coupled with 
measurement of local pulse pressure, which is the difference 
between systolic BP and diastolic BP.1–4   However, the most 
common method for evaluating arterial stiffness is based on the 
study of pulse wave velocity, ie, the velocity of the BP propaga-
tion wave along a given conduit artery, eg, the aorta. Pulse wave 
velocity can be determined from measurements of pulse transit 
time and the distance travelled by the pulse between the common 
carotid and femoral arteries. Aortic pulse wave velocity (carotid 
to femoral) can be measured by applanation tonometry, mecha-
notransducer, or Doppler probes and is regarded as the gold 
standard for determining arterial stiffness, independent of wave 
activity. The technique of applanation tonometry is widely used 
to evaluate central BP and also wave reflections through the 
determination of the augmentation index, a   noninvasive param-
eter (Figure 2). The augmentation index is a measure of the 
contribution that wave reflection makes to the central pressure 
wave. It is defined as the difference between the second and 
first peaks (P2-P1) corresponding to systolic BP and is 
expressed as a percentage of the pulse pressure. Therefore, 
the augmentation index is a quite indirect measure of systemic 
stiffness and is mostly a direct measure of wave reflection, a 
parameter defined later in this review.
It is widely accepted nowadays1 that the aortic BP curve 
represents the mathematical summation of an incident 
  pressure wave, coming from the heart through ventricular 
ejection, and a reflected wave depending on a given arterial 
or arteriolar site characterized by three independent param-
eters, ie, the value of reflection coefficients, the degree of 
arterial stiffening, and the distance between the heart and the 
site of reflecting points (Figure 3). Under normal conditions, 
the complex interaction between these parameters is respon-
sible for the physiologic amplification of the pressure pulse 
observed between central and peripheral arteries, whereas 
mean arterial pressure remains almost constant along the 
arterial tree. Under pathologic conditions, as frequently 
observed in elderly people, particularly those with hyperten-
sion, both increased arterial stiffening and reflection sites 
closer to the heart (ie, reflection sites at the level of arteriolar 
or arterial bifurcations) cause the backward pressure wave 
to return sooner (ie, during the systolic component of the 
aortic BP curve), resulting in a greater summation between 
the forward and backward waves and consequently a higher 
aortic pulse pressure and systolic peak.2,3 In older subjects 
with hypertension, such changes are responsible for a peculiar 
hemodynamic pattern involving a disproportionate increase 
of systolic BP over diastolic BP, with potentially a loss in 
pulse pressure amplification.
Finally, in the past, hypertension was simply defined from 
high mean arterial pressure, associated with elevated systolic 
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Figure 1 The different components of the pulsatile blood pressure curve.1–3 For 
mean arterial pressure, the area under the mean arterial pressure curve is exactly 
equal to the area under the pulsatile blood pressure curve, which means that the 
two curves are able to produce exactly the same cardiac work.1–3International Journal of Nephrology and Renovascular Disease 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
169
Angiotensin II blockade and blood pressure
BP and diastolic BP. Mean arterial pressure divided by cardiac 
output enables calculation of vascular resistance, considered 
to be an index of the caliber of small arteries. Increased vas-
cular resistance some decades ago was considered to be the 
unique and universal hallmark of hypertension. Nowadays, 
the buffering function of large arteries is also taken into con-
sideration. This changing definition is due to the high fre-
quency of systolic hypertension in the elderly, which generates 
mainly increased arterial stiffness and   disturbed wave 
reflections but not necessarily increased vascular resistance.
Hemodynamic effects  
of angiotensin II inhibition  
in hypertension
The point to consider here is that the ACE inhibitor perindo-
pril is able not only to decrease mean arterial pressure but 
also, through its effect on conduit arteries, to decrease 
brachial pulse pressure5–7 and, even more selectively, central 
(carotid and aortic) pulse pressure (see Table 1).
We and others have shown in many previous clinical 
studies that ACE inhibitors may increase arterial diameter 
and decrease arterial stiffness independently of changes in 
mean arterial pressure.8,9 In addition, ACE inhibitors have 
been shown to act selectively on the backward aortic pressure 
wave, causing the reflected wave to return during the diastolic 
(but not the systolic) component of the BP curve, thus 
reducing aortic pulse pressure and systolic peak much more 
than brachial pulse and systolic BP. Thus, the decrease in 
arterial stiffness and change in the pattern of pulse wave 
reflections observed with perindopril contribute significantly 
to a decrease in BP through arterial (and not exclusively 
arteriolar) effects. Both in animals and in humans, there is 
strong evidence to support this assumption, particularly 
following long-term treatment with ACE inhibition. Firstly, 
in spontaneously hypertensive rats and in patients with 
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Figure 2 The augmentation index is the ratio of the difference between peak systolic 
blood pressure, shoulder of the ascending part of the blood pressure curve, and 
pulse pressure.1–4 The augmentation index, measured as a percentage, represents 
the supplementary increase in systolic blood pressure due to wave reflections. This 
hemodynamic profile is observed in the elderly but not in young people (see also 
Figure 3).
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Figure 3 A classical and simple model for the definition of arterial stiffness and wave reflections. Top: a normal youthful arterial tree. Bottom: a stiffened arterial tree of an 
older person. The reflection of the pressure wave is represented by the diastolic wave in the first case (A) and by the late systolic wave in the second case (B). Coronary 
arteries are represented by hooks. PWV is an index of arterial stiffness and is dependent on degree of rigidity (thin line or thick line) of the arterial wall.1–4
Abbreviation: Pwv, pulse wave velocity.International Journal of Nephrology and Renovascular Disease 2010:3 submit your manuscript | www.dovepress.com
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systolic hypertension and end-stage renal disease, ACE 
inhibition restores the aortic pulse pressure amplification 
normally observed from central to peripheral arteries, causing 
a more substantial decrease in carotid than in brachial systolic 
and pulse pressure.6,7 Secondly, in subjects with essential 
  hypertension, ACE inhibitors decrease brachial systolic BP 
more than β-blocking agents for the same decrease in brachial 
diastolic BP and mean arterial pressure.10
REASON (Preterax in Regression of Arterial Stiffness in 
a Controlled Double-blind Study)11 was the first clinical trial 
to investigate the long-term effects of antihypertensive drug 
treatment on central systolic BP and pulse pressure, aortic 
stiffness, and wave reflections. It was conducted in middle-
aged hypertensive subjects. Administration of   perindopril, 
combined with a low dose of the diuretic indapamide, was 
compared with the effect of the β-blocking agent atenolol for 
one year. For the same diastolic BP and mean arterial pressure 
reduction, perindopril plus indapamide lowered systolic BP 
and pulse pressure more than atenolol (Figure 4). Moreover, 
the reduction was significantly more pronounced centrally 
(carotid artery) than peripherally   (brachial artery, Figure 5). 
Although the two drug regimens lowered pulse wave velocity 
equally, only perindopril plus indapamide reduced central 
(carotid) pulse pressure and augmentation index.1–3,11,12 Central 
pulse pressure and   augmentation index remained unchanged 
with atenolol. Furthermore, perindopril plus indapamide 
decreased cardiac hypertrophy more than atenolol. This effect 
was attributed to the augmentation index decline, indicating 
that the reduction of cardiac mass was related to central wave 
reflections.13–15 Furthermore, on drug treatment, the selective 
lowering of systolic BP (but not diastolic BP) with perindopril 
plus indapamide was significantly predicted by the baseline 
pulse wave velocity value. Thus, REASON emphasized the 
predictive values of pulse wave velocity, central systolic BP, 
Table 1 The REASON study population (n = 181) with central (carotid) and brachial measurements11
Time Perindopril plus 
indapamide
Atenolol P value
Brachial systolic BP (mmHg) M0 165.65 ± 1.40 162.18 ± 1.36 0.0786
M6 142.39 ± 1.39* 147.32 ± 1.39* 0.014*
M12 137.80 ± 1.34* 142.88 ± 1.41* 0.0119*
Carotid systolic BP (mmHg) M0 154.46 ± 1.95 152.37 ± 1.90 0.4431
M6 133.34 ± 1.62* 141.23 ± 1.64* 0.0010*
M12 129.50 ± 2.16* 144.99 ± 2.20* ,0.0001*
Brachial-carotid systolic BP (mmHg) 
amplification
M0   9.40 ± 1.54   9.64 ± 1.50 0.9125
M6   6.37 ± 1.50*   2.43 ± 1.54* 0.0709*
M12   8.28 ± 1.53*   0.29 ± 1.61* 0.0006*
Aortic systolic BP (mmHg) M0 155.63 ± 1.83 151.23 ± 1.80 0.0891
M6 135.22 ± 1.78 143.40 ± 1.84 0.0020
M12 128.32 ± 1.97 140.58 ± 2.07 ,0.0001
Brachial carotid or aortic diastolic  
BP (mmHg)
M0   97.09 ± 0.77   96.33 ± 0.75 0.4822
M6   85.10 ± 0.79   85.21 ± 0.79 0.9202
M12   83.93 ± 0.74   83.36 ± 0.78 0.6005
Brachial carotid or aortic 
BP (mmHg)
M0 119.94 ± 0.75 118.28 ± 0.73 0.1137
M6 104.19 ± 0.87 105.92 ± 0.87 0.1659
M12 101.83 ± 0.83 103.26 ± 0.87 0.2463
Carotid augmentation index (%) M0   29.09 ± 2.24   28.77 ± 2.16 0.9175
M6   25.97 ± 2.13   27.74 ± 2.14 0.5608
M12   24.39 ± 1.88*   29.73 ± 1.93* 0.0527*
Aortic augmentation index (%) M0   30.06 ± 0.98   30.30 ± 0.97 0.8616
M6   27.50 ± 0.91*   30.97 ± 0.95* 0.0101*
M12   26.28 ± 0.94*   30.18 ± 1.00* 0.0057*
Pulse wave velocity (m/sec) M0   12.91 ± 0.26   12.46 ± 0.25 0.2161
M6   11.90 ± 0.21   12.02 ± 0.21 0.7008
M12   11.77 ± 0.23   11.90 ± 0.24 0.6945
Note: *Significant intergroup comparisons. Main cardiovascular parameters: adjusted absolute means ± standard error of means are presented at M0, M6, and M12. 
Abbreviations: BP, blood pressure; M, month; REASON, Preterax in Regression of Arterial Stiffness in a Controlled Double-blind Study.International Journal of Nephrology and Renovascular Disease 2010:3 submit your manuscript | www.dovepress.com
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and pulse pressure in the mechanisms of BP reduction in 
hypertensive subjects.16 A confirmation of all these findings 
was obtained later from ASCOT (the Anglo-Scandinavian 
Cardiac Outcomes Trial) in which the role of central BP as 
predictive of cardiovascular events was further confirmed.17
Transduction within  
the arterial wall, pulse pressure,  
and angiotensin II blockade
Mechanical forces involve pulsatile and steady pressure com-
ponents but also have to integrate some biologic   components, 
including those relating to structural and   biochemical factors 
acting on arterial vessels. Focal adhesion formations of extra-
cellular matrix and integrin-specific signaling in vascular 
smooth muscle cells are essential for mechanotransduction of 
angiotensin blockade within the arterial wall.
Dense plaques, which are composed of cytoskeletal 
proteins linked to the extracellular matrix by integrin recep-
tors, are major sites of anchorage between vascular smooth 
muscle and the extracellular matrix. They represent key 
elements for interaction between mechanical forces and 
elastic materials. Integrins exist as αβ pairings. They interact 
with extracellular matrix components, including fibronectin 
(ligand for α5β1 and αvβ3), vitronectin (ligand for αvβ3), 
and laminin (ligand for α6β1).18 Interactions of specific 
extracellular matrix proteins with their integrin receptors 
play a central role in transmitting mechanical forces to 
vascular smooth muscle.19,20 Many of these integrins are 
capable of forming complexes with fibronectin, a glycopro-
tein that plays an important role in the organization and 
assembly of the extracellular matrix.
When cyclic mechanical strain is applied to matrixes con-
taining different adhesion proteins, fibronectin produces one 
of the largest mitogenic responses in rat vascular smooth mus-
cle.20 In addition, expression of fibronectin and its α5β1 receptor 
are increased in the spontaneously hypertensive rat aorta. The 
increase of fibronectin may reflect an increased number of 
mechanical attachments between the extracellular matrix and 
collagen fibers within the media. From a mechanical point of 
view, an increased number of cell matrix attachments promote 
increased stiffness and mechanical strength.
These changes have been studied in situations involving 
normal or increased sodium intake in the presence of angiotensin 
II and/or aldosterone stimulation and blockade.21–26 With a 
normal sodium diet, angiotensin or aldosterone blockade reduces 
mean arterial pressure and pulse pressure, and decreases collagen 
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Figure 4 Overall intention-to-treat population in REASON: adjusted values (±SD) 
in brachial SBP and DBP, measured each month in the perindopril plus indapamide 
and atenolol groups. There was no difference between groups for DBP but only for 
SBP and exclusively at month 12.
Abbreviations: DBP, diastolic blood pressure; Per-Ind, perindopril plus indapamide; 
SBP, systolic blood pressure; M, month; SD, standard deviation; REASON, Preterax 
in Regression of Arterial Stiffness in a Controlled Double-blind Study.
100
Median systolic blood
pressure (mmHg)
No. of person-
years
106
1431
116
4266
125
8974
135
11983
144
9138
154
4942
168
3470
4
5
A
n
n
u
a
l
 
p
a
t
i
e
n
t
 
e
v
e
n
t
 
r
a
t
e
 
(
%
)
6
7
8
9
10
110 120
Achieved systolic blood pressure (mmHg)
1301 40 1501 60 170
Figure  5  Incidence  of  all  renal  events  in  ADvANCe31  according  to  achieved 
blood pressure levels, adjusted for age, gender, duration of diabetes, glycosylated 
hemoglobin,  currently  treated  hypertension,  history  of  macrovascular  disease, 
electrocardiogram  abnormalities  (ventricular  hypertrophy,  Q  waves,  or  atrial 
fibrillation),  triglycerides,  low-density  lipoprotein  cholesterol,  high-density 
lipoprotein cholesterol, body mass index, current smoking, current alcohol use, and 
study drug. Solid boxes represent estimates of event rates, centers of which are 
placed at the intersection of the point estimate and median systolic blood pressure 
value. Areas of the boxes are proportional to the number of events, and vertical 
bars represent 95% confidence interval. The rate of all renal events was significantly 
associated with achieved systolic blood pressure levels (P , 0.0001).
Abbreviation: ADvANCe, Action in Diabetes and vascular Disease: Preterax and 
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accumulation, fibronectin, and its integrin receptor. On a high 
sodium diet, mean arterial pressure, but not central pulse pres-
sure, is reduced in association with collagen accumulation, 
increased fibronectin, and increased arterial stiffness.
It is worth noting that the mechanical contribution of mean 
arterial pressure and pulse pressure may vary markedly accord-
ing to age or the vascular territory involved.27 Thus, pulse 
pressure mechanotransduction may predominate in the heart 
rather than in the brain or kidney because only the former 
territory involves active periodic autocontractions. Further-
more, with increasing age, reflection coefficients are located 
much closer to target organs (ie, the heart, brain, or kidney). 
This finding suggests that pulsatility and wave reflections may 
be transmitted to these organs in the presence of a defect in 
myogenic tone. This defect is commonly observed in subjects 
with type 2 diabetes mellitus, those with uninephrectomy or 
obesity, and often in older patients with systolic hypertension.28–31 
Finally, many factors linked to mechanical stress, particularly 
pulsatility and wave reflections, may affect each particular 
organ locally, thereby modulating or interacting with a local 
hormonal system. A typical example would be subjects with 
hypertension and type 2 diabetes mellitus in whom perindopril 
reduces both systolic BP and renal events.
In conclusion, the renin–angiotensin–aldosterone system 
has been considered for many years only as a hormonal factor 
of the basis of hypertension and its treatment. With the 
development of antihypertensive therapy, the same system 
has come to be understood as a modulating antioxidative and 
anti-inflammatory factor contributing to the reduction of 
cardiovascular morbidity and mortality through its antifi-
brotic effects, mainly observed in the elderly and particularly 
in the large arterial system. This system remains under 
investigation in older populations.
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Table 1 Differences between central and brachial systolic pressure changes related to angiotensin blockade17,32–38
Reference n Drug Difference between 
central and peripheral 
systolic pressure change
Net difference between ACE  
inhibitor/sartan and other  
antihypertensive agents
Asmar et al32 184 
170
Perindopril  
plus indapamide Atenolol
-06 mmHg 
-8.2 mmHg
7.6 mmHg
williams et al17 1042 Amlodipine-perindopril 12.0 mmHg
Morgan et al33 32 Perindopril  
or enalapril
4.7 mmHg
Deary et al34 30 Lisinopril 1 mmHg
Neal et al35 13 Lisinopril 10 mmHg
Hirata et al36 30 Ramipril -2.0 mmHg
Dhakam et al37 21 eprosartan 0 mmHg
Dart et al38 258 ACe inhibitor 1 mmHg
Abbreviation: ACe, angiotensin-converting enzyme.
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